Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infection
Mark W. Kline(Tulane University), Franck Le Duff(Roche (Switzerland)), Heidi Schwarzwald, MONICA EASON(Roche (Switzerland)), Charles Craig(Roche (Switzerland)), Paul Snell(Roche (Switzerland)), Patricia DeLora, Neil Buss, Nancy R. Calles(Texas Children's Hospital), Richard C. Brundage(MelroseWakefield Healthcare), Karin Jorga, Courtney V. Fletcher(University of Nebraska at Omaha)
Cited by 23
Related Papers
Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse-Transcriptase Inhibitors in Children Infected with Human Immunodeficiency Virus Type 1
|New England Journal of Medicine|1999|211
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis
|PLoS Medicine|2018|173
Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2005|151
The Tingathe programme: a pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV (PMTCT) cascade of services in Malawi
|Journal of the International AIDS Society|2012|145